Ventana, Inc.
Country not established
- Devices
- 1
What Ventana, Inc. makes
Ventana, Inc. manufactures primary antibodies, including the VENTANA ER PRIMARY ANTIBODY (CLONE 6F11), used for immunohistochemical staining in diagnostic pathology. These antibodies detect estrogen receptors in tissue samples to aid in breast cancer diagnosis and treatment planning.
The company’s products fall under FDA Class II devices and are authorised through the 510(k) clearance pathway. The portfolio is listed in the FDA’s 510(k) registry, and the manufacturer is based in the United States.
Catalogue
Ventana Er Primary Antibody (Clone 6F11) Ref K984567
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Ventana, Inc. have in the registry?
The registry currently lists 1 device for Ventana, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Ventana, Inc.'s devices?
Among its 1 most recently registered device, Ventana, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Ventana, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Ventana, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Ventana, Inc. in the registry?
The most recently registered devices listed for Ventana, Inc. include VENTANA ER PRIMARY ANTIBODY (CLONE 6F11).